Genscript Biotech Corporation announced that Ms. Wang Jiafen had tendered resignation from her positions as a non-executive director and a member of the strategy committee of the Company due to the attainment of statutory retirement age, with effect from 5 July 2024; and Dr. Wang Xuehai had tendered resignation from his position as an independent non-executive Director due to his intention to devote more time to other business commitments, with effect from 5 July 2024. The Board further announces that, with effect from 5 July 2024, Ms. Wang ceased to be a member of the Strategy Committee and Dr. Shi Chenyang, an independent non-executive Director of the Company, has been appointed as a new member of the Strategy Committee.